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A B S T R A C T
Interactions of MinK and e-NOS Gene Polymorphisms Appear to Be Inconsistent Predictors of Atrial Fibrillation
Propensity, but Long Alleles of ESR1 Promoter TA Repeat May Be a Promising Marker. We analyzed minK, e-NOS and
ESR1 gene polymorphisms in 40 patients with atrial fibrillation (AF) without major structural heart disease compared
to 35 healthy controls. A missense polymorphism in the minK gene with A/G substitution at nucleotide 112 causing
serine (S) to glycine (G) change, 786 T/C polymorphism in the 5’ flanking region of e-NOS gene and TA polymorphism in
the regulatory region of estrogen receptor ESR1 gene with long (19 TA repeats) and short alleles were examined. Only a
slight increase in minK G allele frequency, but with marked excess in AG/TT combination of minK and e-NOS poly-
morphisms was found in the AF group. The interpretation remains tentative due to small groups precluding statistical
significance of differences, possible lab flaws and inconsistencies with earlier data. However, ESR1 long allele homozy-
gotes were strikingly more frequent in the AF than in control group, reaching statistical significance surprisingly in
males (p<0.02). Functional activity of estrogen receptors may be more critical in males than in females with abundance
of circulating estrogen. Contrasting the intricate complexity of genetic polymorphisms influencing cardiac rhythm with
our modest research, we would limit the conclusion to the plea for further research of ESR1 role in AF.
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Introduction
The genetics of atrial fibrillation (AF) has evoked con-
siderable interest since R. Brugada identified one of the
loci for familial AF ten years ago1. It appeared that AF, a
paramount arrhythmia, may have genetic determinants.
The modes of inheritance include simple monogenic and
complex polygenic traits2. Genetic polymorphisms are
less conspicuous, but more common cause of AF than
rare monogenic inheritance with ion channel or struc-
tural protein alterations2. Among many polymorphisms
investigated2, we confined our research to three of them:
minK, eNOS and estrogen receptor á genes.
Human minK protein is the b-subunit of Iks potassium
channel enhancing atrial repolarization21. A missense
polymorphism in the minK gene has been reported to fa-
cilitate AF. It comprises A/G substitution at nucleotide
112 of the minK gene, causing serine to glycine change in
the 38 aminoacidic position of the minK protein3.
Deficiency in nitric oxygen (NO) may promote AF3.
NO through cGMP stimulates antiarrhythmic calcium
channel modulation and inhibits transient outward po-
tassium current (Ito1) restoring plateau phase of AF re-
modelled action potential. Low NO levels increase Ca++
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current ICa,L and reduce muscarinic K+ current IKACh. NO
levels are regulated by nitric oxygen synthases (NOS),
endothelial NOS (eNOS) being essential. NOS are pri-
mordial regulators of fundamental cardiac functions, in-
cluding cardiac autonomic balance and L-type calcium
channel function, pivotal for sinus rhythm3,4. Inducible
NOS enhance superoxide production and electrical re-
modelling in AF. Some eNOS polymorphisms may reduce
plasma NO levels: guanine to thymine substitution at
nucleotide 894 in exon 7 (894 G>T polymorphism), the C
allele of the 786 T>C polymorphism in the 5’ flanking re-
gion and a 27 bp variable tandem repeats polymorphism
in intron 4 (eNOS 4a4b)3.
While the role of minK and eNOS polymorphisms in
AF has been already studied, estrogen gene receptor
polymorphisms have been linked to ventricular arrhy-
thmias only5. Women of childbearing age have faster
resting heart rates and longer QTc intervals than men
with distinctive appearance of final ECG complex and
propensity for drug and bradycardia induced polymor-
phic ventricular tachycardia5. Gender related differences
of repolarisation caused by estrogens, gestagens and an-
drogens with receptors in cardiomyocites and fibroblasts
are inferred. The data on electrophysiological effects of
sex steroids are scarce. They might modulate proarrhy-
thmic response through IKr and ICa,L currents5. Estrogen
(17b-estradiol) regulates expression of many genes
through estrogen receptors á (gene ESR1) and b (ESR2)6.
ESR1 polymorphisms alter expression of many genes, in-
cluding those of eNOS and inducible NOS6. Estrogen
stimulates NO production in vessels by increasing the ex-
pression of NOS and NO release from endothelium. It
also influences the L-type Ca2+ channel gene expression6.
Receptor mediated estrogen electrophysiological effects
can be conceived independently from more investigated
vascular and myocardial effects. Of the polymorphisms
identified in the ESR1 gene, the c.454-397T>C (also
known as IVS1-397 T/C, rs2234693, and the PvuII re-
striction site) and c.454-351 A>G (also known as
IVS1-351 A/G, rs9340799, and the XbaI restriction site)
have been the most studied6. We have chosen promoter
TA dinucleotide repeat polymorphism in the regulatory
region of ESR1 gene instead. The long allele has been as-
sociated with increased cardiovascular risk profile7.
We considered the research of minK, eNOS and ESR1
gene polymorphisms in patients with AF without gross
structural cardiac abnormality worthwhile. Those pa-
tients were selected to avoid smothering of inheritance
by dominant exogenous factors. Electrical instability cau-
sed by certain polymorphisms or their combinations may
render atria prone to fibrillation. MinK and eNOS poly-
morphisms have been studied in limited populations3,8,9,
while ESR1 polymorphisms have not been associated
with AF yet.
Patients and Methods
We analyzed minK, e-NOS and ESR1 polymorphisms
in 40 patients with AF and 35 healthy controls. Only the
patients without major structural heart disease were in-
cluded, as inferred from clinical examination, ECG and
echocardiography. The group with AF comprised 23 pa-
tients with lone AF and 17 hypertensives without frank
left ventricular hypertrophy or other features of hyper-
tensive heart disease. AF group consisted of 23 males
aged 50.0±14.8 (X±SD), range 20–74 years and 17 females
aged 57.6±14.2, range 31–77 years. Echocardiographic di-
mensions in AF patients were normal, or nearly normal:
LVIDd 5.2±0.6, range 4.0–5.8 cm, IVSTh 1.13±0.16,
range 0.7–1.3 cm and PWTh 1.01±0.15 cm, range 0.7–1.3
cm, LA 3.8±0.7 cm, range 2.3–4.5 cm. Left ventricular
systolic and diastolic function were normal or borderline
in all AF patients, with ejection fraction of 65.3±5.5%,
range 53–77%. Control group consisted of 35 healthy vol-
unteers from hospital staff, aged 40.6±13.3, range 24–70
years, 11 males and 24 females.
The frequencies of A and G alleles of minK gene with
respective genotypes were assessed, as well as C and T al-
leles of e-NOS gene. Among the estrogen receptor gene
polymorphisms related to heart disease, we selected long
(L) with 19 TA repeats (178–194 bp) and short (S) al-
leles with <19 TA repeats (160–176 bp). The methods
used were PCR and RFLP for minK and eNOS polymor-
phisms, as well as PCR and capillary electrophoresis for
ESR1 polymorphisms.
In addition to analysis of particular alleles, we studied
their combinations.
c2 test with Yates’ correction, Fisher’s exact test and
logistic regression analysis were used for statistical anal-
ysis.
Results
The frequency of minK G allele in patients with AF
was 32.50%, hardly any higher then in controls with
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TABLE 1
MINK, E-NOS AND ESR1 POLYMORPHISMS IN AF AND CON-
TROL PATIENTS
AF (n=40) Controls (n=35)
Gene Genotype n % n %
minK
AA 14 35 13 37.14
AG 26 65 22 62.86
e-NOS
TT 18 45 12 34.29
TC 22 55 23 65.71
minK +
+ e-NOS
AATT 7 17.5 8 22.86
AGTT 11 27.5 4 11.43
AGTC 15 37.5 17 48.57
AATC 7 17.5 6 17.14
ESR1
SS 11 27.50 11 31.43
SL 16 40.00 18 51.43
LL 13 32.50 6 17.14
* The differences are most pronounced for AGTT minK/e-NOS
combination and LL allele of ESR1 gene, but in a small sample
are not statistically significant.
31.43%. Only AA homozygotes and AG heterozygotes,
but not GG homozygotes were found.
Surprisingly, T allele of e-NOS gene was more fre-
quent in the group of AF patients than in controls (72.50
vs. 67.14%), opposite to C allele incriminated earlier as
possibly arrhythmogenic. The difference was insignifi-
cant, but AG/TT combination of minK and e-NOS alleles
was not far from reaching the statistical significance (Ta-
ble 1). Astoundingly, not a single case of CC homozy-
gosity was found.
Long allele of ESR1 gene was more frequent in AF
than in control group (52.50 vs. 42.86%), but the differ-
ence was insignificant. The homozygotes for long allele
(LL) were twice as frequent in AF as in control group. In
spite of the striking difference, the level of statistical sig-
nificance has not been reached yet, due to the small num-
ber of examinees. In the group of 40 patients with AF,
only 6 were women with the first occurrence AF in child-
bearing age, too few for further differentiation.
Surprisingly, statistical significance for p<0.02 (Fi-
sher’s exact test) was reached in males. Nine out of 23
males with AF and none of eleven male controls were LL
homozygotes (Figure 1). Logistic regression analysis re-
vealed male gender and LL allele as the most significant
risk factors for AF (p=0.013).
Discussion
The aetiology of AF is an unavoidable topic in contem-
porary cardiology due to its clinical relevance and per-
plexing complexity. Advancements of experimental and
clinical electrophysiology have contributed to better un-
derstanding of AF initiation, perpetuation and therapy10.
However, the primary causes remain obscured in a co-
nundrum of confounding risk factors. Genetic propensity
to AF has been increasingly recognized in the last de-
cade2. It can be discerned if the exogenous factors are
corrected statistically, or the patients with lone AF are
selected11.
The research of genetic polymorphisms in AF is an ex-
ceedingly arduous task. The effects of a single polymor-
phism are presumably weak2. Its phenotypic expression
may vary in a hardly decipherable manner and appear
through intricate interactions of cellular biology. Syner-
gistic polymorphisms may reach phenotypic expression
in combinations only. There is a myriad of putative
polymorphisms and interactions of their expressions. Al-
beit weak separately, they may be significant in constel-
lation. Detecting weak factors in a complex system is dif-
ficult. It may be compared to a mosaic consisting of tiny
and seemingly trifling pieces, which put together in a
very specific way form an elaborate image.
This figurative concept may explain two standpoints:
1/ the interpretation of small studies should be very cau-
tious since they represent only a small part of an elabo-
rate picture and 2/ inconsistencies between studies are
not necessarily contradictions. They may point to differ-
ent aspects of the same problem. We believe that small
studies may be helpful in finding useful clues for the
forthcoming research, even without clear-cut answers.
In our small group, the influence of min-K and e-NOS
polymorphisms on AF was not obvious. The main limita-
tion was insufficient number of examinees. Group of
double size could have yielded more reliable results. Se-
lecting the patients without major structural heart dis-
ease and obscuring of genetic causes by exogenous fac-
tors alleviates the problem.
There are only a few reports on minK polymorphisms
and AF. The association unravelled by a Chinese re-
search8 was confirmed by two European studies3,9 in a
modest number of patients. The data on e-NOS gene
polymorphisms in association with AF are even fewer2,3.
The lack of data may be due to limited availability of mo-
lecular diagnostics.
We were not able to confirm prior data. The trend of
increased frequency of minK G allele among the patients
with AF was the same, but far less convincing and statis-
tically insignificant. In previous studies, two of them
with unselected AF patients3,8, and one with lone AF9,
the differences were driven primarily by GG homoyzgo-
tes. Astoundingly, we have found none of them. The only
probable explanation is a flaw in laboratory technique
with insufficient sensitivity in differentiating AG and
GG genotypes. In this case, some GG genotypes were er-
roneously recognized as AG ones, underestimating the
frequency of G allele. The probability that GG genotypes
were missing entirely is diminutive, considering the expe-
cted allele proportions in HardyWeinberg’s equilibrium.
Negative association of AF with e-NOS C allele and
reverse one with T allele are in discordance with prior
data3. Unexpected results are statistically insignificant
and may be dismissed as a chance finding in a small sam-
ple. They are still noteworthy. Although C allele may pre-
dispose to AF in synergy with minK G allele by reduction
of NO synthesis3, the concept has been not investigated
sufficiently. The intricate pathways of e-NOS influence
on atrial arrhythmogenesis are largely speculative. Un-
expected results are possible as a part of yet unknown
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Fig. 1. Nine out of twenty three males with AF and none of eleven
male controls were LL homozygotes (p<0,02, Fisher’s exact test).
Eight males with AF had SL and six SS genotype. Seven control
males had SL and four SS genotype.
mechanisms. Thus, the possibility of TT genotype predis-
posing to AF in certain conditions more than CD geno-
type should not be disregarded.
The problem of missing CC genotype in our study
could be commented similarly as the difficulty with minK
GG genotype. The phenotypic differences of CC and CT
genotypes are not necessarily limited to the quantity of
effects. Assumptions on dominant, co-dominant and re-
cessive modes of inheritance, valid for monogenic traits,
are usually oversimplifications if applied to complex sys-
tems of polygenic inheritance. We should refrain from
speculating on riddles with too many unknowns.
Coupling the polymorphisms of different genes in a
statistical analysis may help discovering synergistic path-
ways6, but playing with numbers to attain statistical sig-
nificance has to be avoided. Coupling of minK and e-NOS
polymorphisms had been already tried3, but further com-
binations with ESR1 polymorphisms seemed inappropri-
ate in our small group. Putative interactions are manifold.
Pursuing advancement in gene polymorphism resea-
rch in AF a step beyond the concepts already tried, we
have paid attention to estrogen receptor gene. It has
been studied extensively in bone metabolism, cancer re-
search, vascular biology, atherosclerotic heart disease and
myocardial hypertrophy. Ventricular arrhythmogenesis
has been tackled5, but atrial arrhythmias have not been
investigated yet. AF is 1.5 times more common in males
than in females, even if prevalence is corrected by risk
factors12. The prevalence of lone AF is also markedly
higher in males12. Furthermore, estrogen effects are not
limited to women in childbearing age, but are exerted
later on and in males.
Long alleles of ESR1 gene have been reported to in-
crease risk of coronary artery disease7. To our knowl-
edge, there are no reports on predisposing to AF. In our
study, the frequency of long alleles was modestly in-
creased in AF patients compared with controls, but the
proportion of LL homozygotes was doubled. The trend
was remarkable, even if not expected to stay at this level
in further research (the impact of a single polymorphism
is presumably weak). The data are stimulating further
research, especially in younger women where the effects
of estrogens are supposedly most pronounced.
From the other point of view, the ESR1 polymor-
phism may be even more important in postmenopausal
women and men: with less estrogen available, functional
quality of receptors may be decisive. This is a tentative
explanation for unexpected result that LL genotype is
more relevant for AF in males than in females. We are
well aware of the limitations. The groups are small and
not well age-matched, but the results are still challenging.
In comparison with already published data3,8,9, the
frequencies of minK G allele and e-NOS C-allele in our
study are at the lower end of range. This may reflect the
underestimation due to the faulty assessment of GG and
CC homozygotes. With a wide range of frequencies in
studies from different populations, the question arises if
some populations are more prone to AF than the others.
Publication of our research may be disputed as pre-
mature. The results would be more reliable with more
patients. Double-checking may solve the problems of
missing minK GG and e-NOS CC homozygotes. However,
further research depends on affordability of genetic test-
ing which is at present time uncertain. Therefore, we
opted for publication.
In conclusion, we tried to contribute modestly to the
solution of intricate puzzle of AF genetic background. In
view of minK and e-NOS gene polymorphisms, we cre-
ated more questions than answers. However, some in-
kling that ESR1 gene long alleles may predispose to AF,
especially in males, has been found. The results are in-
spiring further research.
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INTERAKCIJE POLIMORFIZAMA MINK I E-NOS GENA SU DVOJBENI PREDSKAZATELJI
FIBRILACIJE ATRIJA, ALI DUGI ESR1 ALELI S TA PONAVLJANJEM U PROMOTORSKOM
DIJELU MOGLI BI BITI OBE]AVAJ]I BILJEG
S A @ E T A K
Analizirali smo polimorfizme minK, e-NOS and ESR1 gena u 40 pacijenata s atrijskom fibrilacijom (AF), a bez ve}e
strukturne bolesti srca, u usporedbi s 35 zdravih ispitanika kontrolne skupine. Ispitivani su misens polimorfizamminK
gena s A/G supstitucijom u 112. nukleotidu uzrokuju}i zamjenu serina (S) glicinom (G), 786 T/C polymorfizam u 5’
pobo~noj regiji e-NOS gena i TA polimorfizam u regulatornoj regiji ESR1 gena za estrogenski receptor s dugim (19 TA
ponavljanja) i kratkim alelima. U AF skupini na|en je tek lagan porast frekvencije minK G alela, ali s izrazitim vi{kom
AG/TT kombinacije minK i e-NOS polimorfizama. Tuma~enje je zasad dvojbeno zbog malih skupina bez dosizanja
statisti~ke zna~ajnosti razlika, mogu}ih laboratorijskih pogre{aka i neslaganja s dosada{njim podacima. Homozigoti za
duge alele ESR1 gena bili su ipak upadljivo ~e{}i u AF, nego u kontrolnoj skupini, za~udo dosi`u}i statasti~ku zna~ajnost
razlike u mu{karaca (p<0,02). Funkcionalna aktivnost estrogenskih receptora mogla bi biti presudnija u mu{karaca
nego u `ena s obiljem cirkuliraju}ih estrogena. Suprostavljaju}i zamr{enu slo`enost genskih polimorfizama koji utje~u
na sr~ani ritam skromnosti na{eg istra`ivanja, ograni~ili bismo zaklju~ak na apel za nastavak istra`ivanja uloge ESR1
gena u atrijskoj fibrilaciji.
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